Josh Enomoto

Josh Enomoto

As a financial analyst who has engaged in multimillion dollar projects with Global 500 companies, Joshua Enomoto provides an acute perspective of the investment markets.

A graduate of the University of California, San Diego, his professional experience covers multiple industries, including healthcare, civil engineering, and consumer electronics. Past contributions include leading the resolution of a critical liabilities dispute between two major electronics companies, and being awarded a speaking engagement in Tokyo, Japan, regarding supply chain efficiency protocols.

Currently based in San Diego, Josh is also an avid music composer and audio engineer, and spends his free time with multimedia pursuits.

Recent Articles

8 Presidential Election Stocks to Buy in Case Trump Wins Again

It might seem like the longest of long shots. However, there’s still a chance that President Trump will win his second term and that means you need to adjust your strategy for presidential stocks to buy.

Canopy Growth Is Intriguing If You Can Get Over the Credibility Issue

After so many misses, Canopy Growth stock suffers from a credibility drain. Nevertheless, political and medicinal shifts present an interesting contrarian case for CGC.

The Good, Bad, and Ugly for Energy Transfer

A few weeks was all it took to deflate the comeback narrative for ET stock. Here are the factors that could play a big role in where Energy Transfer goes from here.

How the U.S. Constitution Is Helping Inovio Pharmaceuticals

INO stock has transformed this year from unknown to a Wall Street darling. But with a worsening pandemic, the long-term case for Inovio has become even more credible.

7 Gun Stocks to Buy During the Coronavirus Pandemic

Gun stocks have always been controversial due to the underlying product. However, with a record number of Americans wishing to protect themselves, this investment sector just got very interesting.